Robert Coffey

September 27, 2018

Cancer Moonshot award to help map tumor progression

A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

By Tom Wilemon
October 19, 2017

Symposium honors Moses’ storied cancer research career

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.

By VUMC News and Communications
October 17, 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.

By Leigh MacMillan
June 8, 2017

Coffey lands major NCI award to support colorectal cancer research

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

By Bill Snyder
May 18, 2017

Glowing receptors help find and track cancerous growth

Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth.

By Bill Snyder
A large audience wearing 3D glasses in a darkened movie theater.
March 23, 2017

Study takes 3-D perspective on colorectal cancer

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

By Bill Snyder
June 2, 2016

‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.
By VUMC News and Communications
March 24, 2016

Singer’s concert honors care received at Cancer Center

A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center.
By VUMC News and Communications
February 18, 2016

Study explores less invasive way to monitor colorectal cancer

Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.
By VUMC News and Communications
September 3, 2015

Bad “traffic” linked to cancer

Understanding how signaling molecules are transported within and out of the cell may help to uncover the causes of certain cancers.
By VUMC News and Communications
July 30, 2015

Study sheds light on human gut’s ‘pacemaker’ cells

The gut has its own built-in pacemakers, populations of specialized cells that control smooth muscle contraction in the stomach, small intestine and colon.
By Bill Snyder
April 3, 2014

Protein’s role in spread of colon cancer studied

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.
By VUMC News and Communications
August 15, 2013

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.
By Bill Snyder
1 2 3